Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

Asim Amin, David H. Lawson, April K.S. Salama, Henry B. Koon, Troy Guthrie, Sajeve S. Thomas, Steven J. O'Day, Montaser F. Shaheen, Bin Zhang, Stephen Francis, F. Stephen Hodi

Research output: Contribution to journal › Article › peer-review